Avita Medical Inc - Asset Resilience Ratio
Avita Medical Inc (AVH) has an Asset Resilience Ratio of 32.24% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2025)
This chart shows how Avita Medical Inc's Asset Resilience Ratio has changed over time. Check Avita Medical Inc (AVH) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Avita Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Avita Medical Inc market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$10.24 Million | 18.15% |
| Short-term Investments | AU$7.95 Million | 14.08% |
| Total Liquid Assets | AU$18.19 Million | 32.24% |
Asset Resilience Insights
- Very High Liquidity: Avita Medical Inc maintains exceptional liquid asset reserves at 32.24% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Avita Medical Inc Industry Peers by Asset Resilience Ratio
Compare Avita Medical Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Bactiguard Holding AB (publ)
ST:BACTI-B |
Medical Devices | 8.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
Annual Asset Resilience Ratio for Avita Medical Inc (2000–2025)
The table below shows the annual Asset Resilience Ratio data for Avita Medical Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 45.02% | AU$35.88 Million ≈ $25.39 Million |
AU$79.71 Million ≈ $56.40 Million |
-34.75pp |
| 2024-06-30 | 79.77% | AU$89.06 Million ≈ $63.01 Million |
AU$111.64 Million ≈ $78.99 Million |
+4.93pp |
| 2023-06-30 | 74.84% | AU$108.03 Million ≈ $76.44 Million |
AU$144.34 Million ≈ $102.13 Million |
+14.52pp |
| 2022-06-30 | 60.32% | AU$96.32 Million ≈ $68.15 Million |
AU$159.67 Million ≈ $112.98 Million |
-- |
| 2020-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$119.49 Million ≈ $84.54 Million |
-- |
| 2019-06-30 | 1.09% | AU$281.70K ≈ $199.32K |
AU$25.73 Million ≈ $18.20 Million |
-- |
| 2017-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$7.67 Million ≈ $5.43 Million |
-- |
| 2016-06-30 | 6.24% | AU$537.05K ≈ $380.00K |
AU$8.60 Million ≈ $6.09 Million |
-43.71pp |
| 2015-06-30 | 49.95% | AU$2.72 Million ≈ $1.92 Million |
AU$5.44 Million ≈ $3.85 Million |
+10.53pp |
| 2014-06-30 | 39.42% | AU$2.88 Million ≈ $2.04 Million |
AU$7.31 Million ≈ $5.17 Million |
+39.06pp |
| 2011-06-30 | 0.36% | AU$67.33K ≈ $47.64K |
AU$18.69 Million ≈ $13.22 Million |
-1.80pp |
| 2010-06-30 | 2.16% | AU$169.97K ≈ $120.27K |
AU$7.86 Million ≈ $5.56 Million |
-1.91pp |
| 2009-06-30 | 4.07% | AU$322.82K ≈ $228.42K |
AU$7.93 Million ≈ $5.61 Million |
+1.60pp |
| 2008-06-30 | 2.47% | AU$382.70K ≈ $270.78K |
AU$15.51 Million ≈ $10.97 Million |
+0.03pp |
| 2003-06-30 | 2.44% | AU$209.00K ≈ $147.88K |
AU$8.56 Million ≈ $6.06 Million |
+1.03pp |
| 2002-12-31 | 1.42% | AU$216.00K ≈ $152.83K |
AU$15.26 Million ≈ $10.80 Million |
-11.77pp |
| 2002-06-30 | 13.19% | AU$667.06K ≈ $471.99K |
AU$5.06 Million ≈ $3.58 Million |
-10.50pp |
| 2001-06-30 | 23.69% | AU$1.28 Million ≈ $908.04K |
AU$5.42 Million ≈ $3.83 Million |
-2.46pp |
| 2000-06-30 | 26.14% | AU$733.43K ≈ $518.95K |
AU$2.81 Million ≈ $1.99 Million |
-- |
About Avita Medical Inc
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more